NO982290D0 - Merkaptoalkylpeptidyl-forbindelser som har en imidazolsubstituent og deres anvendelse som inhibitorer av matriks-metalloproteinaser (MMP) og/eller tumor nekrosefaktor (TNF) - Google Patents
Merkaptoalkylpeptidyl-forbindelser som har en imidazolsubstituent og deres anvendelse som inhibitorer av matriks-metalloproteinaser (MMP) og/eller tumor nekrosefaktor (TNF)Info
- Publication number
- NO982290D0 NO982290D0 NO982290A NO982290A NO982290D0 NO 982290 D0 NO982290 D0 NO 982290D0 NO 982290 A NO982290 A NO 982290A NO 982290 A NO982290 A NO 982290A NO 982290 D0 NO982290 D0 NO 982290D0
- Authority
- NO
- Norway
- Prior art keywords
- necrosis factor
- mercaptoalkyl
- mmp
- tnf
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9523828.3A GB9523828D0 (en) | 1995-11-22 | 1995-11-22 | Compounds |
GBGB9607121.2A GB9607121D0 (en) | 1996-04-04 | 1996-04-04 | Compounds |
PCT/GB1996/002892 WO1997019075A1 (en) | 1995-11-22 | 1996-11-22 | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
Publications (2)
Publication Number | Publication Date |
---|---|
NO982290D0 true NO982290D0 (no) | 1998-05-20 |
NO982290L NO982290L (no) | 1998-05-20 |
Family
ID=26308152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO982290A NO982290L (no) | 1995-11-22 | 1998-05-20 | Merkaptoalkylpeptidyl-forbindelser som har en imidazolsubstituent og deres anvendelse som inhibitorer av matriks-metalloproteinaser (MMP) og/eller tumor nekrosefaktor (TNF) |
Country Status (19)
Country | Link |
---|---|
US (1) | US6048841A (cs) |
EP (1) | EP0874842B1 (cs) |
JP (1) | JP2000500482A (cs) |
KR (1) | KR19990067687A (cs) |
CN (1) | CN1072667C (cs) |
AT (1) | ATE215946T1 (cs) |
AU (1) | AU711907B2 (cs) |
BR (1) | BR9611636A (cs) |
CA (1) | CA2229438C (cs) |
CZ (1) | CZ291337B6 (cs) |
DE (1) | DE69620639T2 (cs) |
ES (1) | ES2172690T3 (cs) |
HU (1) | HUP9904131A3 (cs) |
IL (1) | IL123431A (cs) |
MX (1) | MX9804052A (cs) |
NO (1) | NO982290L (cs) |
NZ (1) | NZ322565A (cs) |
PL (1) | PL326710A1 (cs) |
WO (1) | WO1997019075A1 (cs) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
RU2201931C2 (ru) | 1996-11-20 | 2003-04-10 | Биомежер Инкорпорэйтед | Ингибиторы фарнезилтрансферазы и способы ингибирования фарнезилтрансферазы |
EP1294699B1 (en) | 2000-05-12 | 2016-04-13 | Genzyme Corporation | Modulators of tnf- alpha signalling |
US6809100B2 (en) | 2000-05-15 | 2004-10-26 | Darwin Discovery Ltd. | Hydroxamic acid derivatives |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
NZ533958A (en) * | 2002-01-07 | 2007-09-28 | Eisai Co Ltd | Deazapurines and uses thereof |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
DE60335652D1 (de) * | 2002-11-21 | 2011-02-17 | Genzyme Corp | Verwendung eines diamidderivats zur verhinderung der chronischen transplantatabstossung |
JP4914008B2 (ja) * | 2002-11-21 | 2012-04-11 | ジェンザイム・コーポレーション | 免疫寛容を誘導するためのジアミド誘導体と免疫抑制剤との組み合わせ |
US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993020047A1 (en) * | 1992-04-07 | 1993-10-14 | British Bio-Technology Limited | Hydroxamic acid based collagenase and cytokine inhibitors |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
GB9404046D0 (en) * | 1994-03-03 | 1994-04-20 | Smithkline Beecham Corp | Novel compounds |
JP3787605B2 (ja) * | 1994-10-05 | 2006-06-21 | ダーウィン・ディスカバリー・リミテッド | ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用 |
-
1996
- 1996-11-22 EP EP96939208A patent/EP0874842B1/en not_active Expired - Lifetime
- 1996-11-22 WO PCT/GB1996/002892 patent/WO1997019075A1/en not_active Application Discontinuation
- 1996-11-22 CA CA002229438A patent/CA2229438C/en not_active Expired - Fee Related
- 1996-11-22 KR KR1019980703717A patent/KR19990067687A/ko not_active Application Discontinuation
- 1996-11-22 DE DE69620639T patent/DE69620639T2/de not_active Expired - Fee Related
- 1996-11-22 CZ CZ19981455A patent/CZ291337B6/cs not_active IP Right Cessation
- 1996-11-22 NZ NZ322565A patent/NZ322565A/xx unknown
- 1996-11-22 CN CN96198507A patent/CN1072667C/zh not_active Expired - Fee Related
- 1996-11-22 US US08/755,071 patent/US6048841A/en not_active Expired - Fee Related
- 1996-11-22 JP JP9519522A patent/JP2000500482A/ja not_active Ceased
- 1996-11-22 AT AT96939208T patent/ATE215946T1/de not_active IP Right Cessation
- 1996-11-22 ES ES96939208T patent/ES2172690T3/es not_active Expired - Lifetime
- 1996-11-22 PL PL96326710A patent/PL326710A1/xx unknown
- 1996-11-22 IL IL12343196A patent/IL123431A/en not_active IP Right Cessation
- 1996-11-22 HU HU9904131A patent/HUP9904131A3/hu unknown
- 1996-11-22 BR BR9611636-6A patent/BR9611636A/pt unknown
- 1996-11-22 AU AU76343/96A patent/AU711907B2/en not_active Ceased
-
1998
- 1998-05-20 NO NO982290A patent/NO982290L/no not_active Application Discontinuation
- 1998-05-21 MX MX9804052A patent/MX9804052A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU711907B2 (en) | 1999-10-21 |
WO1997019075A1 (en) | 1997-05-29 |
JP2000500482A (ja) | 2000-01-18 |
CA2229438C (en) | 2006-01-17 |
MX9804052A (es) | 1998-09-30 |
HUP9904131A3 (en) | 2002-04-29 |
IL123431A0 (en) | 1998-09-24 |
US6048841A (en) | 2000-04-11 |
DE69620639T2 (de) | 2002-10-17 |
KR19990067687A (ko) | 1999-08-25 |
PL326710A1 (en) | 1998-10-26 |
ES2172690T3 (es) | 2002-10-01 |
ATE215946T1 (de) | 2002-04-15 |
DE69620639D1 (de) | 2002-05-16 |
NZ322565A (en) | 1999-11-29 |
CZ291337B6 (cs) | 2003-02-12 |
EP0874842B1 (en) | 2002-04-10 |
CA2229438A1 (en) | 1997-05-29 |
CN1202895A (zh) | 1998-12-23 |
CZ145598A3 (cs) | 1998-08-12 |
CN1072667C (zh) | 2001-10-10 |
EP0874842A1 (en) | 1998-11-04 |
AU7634396A (en) | 1997-06-11 |
NO982290L (no) | 1998-05-20 |
BR9611636A (pt) | 1999-12-28 |
IL123431A (en) | 2001-05-20 |
HUP9904131A2 (hu) | 2000-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO982290D0 (no) | Merkaptoalkylpeptidyl-forbindelser som har en imidazolsubstituent og deres anvendelse som inhibitorer av matriks-metalloproteinaser (MMP) og/eller tumor nekrosefaktor (TNF) | |
DK0728144T3 (da) | Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer af metalloproteinaser | |
DK0968182T3 (da) | Hydroxam- og carboxylsyrederivater med MMP- og TNF-inhiberende aktivitet | |
NO20000784L (no) | Nye aggrecanaseinhibitorer og matriksmetalloproteinaser for behandling av artritt | |
NO982185L (no) | Nye makrosykliske forbindelser som metalloproteinaseinhibitorer | |
FI971412A (fi) | Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä | |
NO20005448D0 (no) | Indolderivater og deres anvendelse for behandling av maligne og andre sykdommer som er basert pÕ patologisk celleproliferering | |
DK0841929T3 (da) | Quinoloner og deres terapeutiske anvendelse | |
ES2101358T3 (es) | Inhibicion de la produccion de tnf. | |
ATE231837T1 (de) | Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung | |
NO20053486L (no) | 2-(1H-indazol-6-ylamin)-benzamidforbindelser som proteinkinase inhibitorer anvendelig for behanding av oftalmiske sykdommer | |
NO963860L (no) | Isoprenyl-transferase-inhibitorer | |
NO942641L (no) | Inhibisjon av fosfatidylinositol 3-kinase med wortmannin og analoger derav | |
BR9814817A (pt) | Inibidores de apoptose de dipeptìdio e o uso dos mesmos | |
DK0650483T3 (da) | (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer | |
NO985095D0 (no) | Substituerte indazolderivater og deres anvendelse som inhibitorer fosfodiesterase (PDE) type IV og produksjon av tumornekrosefaktor (TNF) | |
MX9802680A (es) | Peptidos substituidos como inhibidores para metaloproteinasas y liberacion de tnf. | |
ATE263569T1 (de) | Unterdrückung von inhibitoren | |
NO20003868L (no) | Hydroksam- og karboksylsyrederivater | |
NO20003828L (no) | 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepin-3-hydroksamsyrer som matriks-metalloproteinase inhibitorer | |
NO952601L (no) | Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser | |
ATE250030T1 (de) | Peptidverbindungen mit mmp- und tnf-hemmender wirkung | |
DE69828638D1 (de) | Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität | |
NO972906D0 (no) | 4,4-(Disubstituerte)cykloheksan-1-ol-monomerer og beslektede forbindelser | |
SE0203479D0 (sv) | Novel drug target |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |